Insider Selling: Syndax Pharmaceuticals (NASDAQ:SNDX) CFO Sells 2,082 Shares of Stock
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) CFO Keith Goldan sold 2,082 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $20.62, for a total value of $42,930.84. Following the sale, the chief financial officer owned 143,839 shares in the company, valued […]
7 Feb 00:26 · The Markets Daily